Omega-3 and Pulmonary toxicity - a phase IV clinical study of FDA data

Summary:

Pulmonary toxicity is reported only by a few people who take Omega-3.

The phase IV clinical study analyzes which people take Omega-3 and have Pulmonary toxicity. It is created by eHealthMe based on reports of 1,598 people who have side effects while taking Omega-3 from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

1,598 people reported to have side effects when taking Omega-3.
Among them, 3 people (0.19%) have Pulmonary toxicity.

What is Omega-3?

Omega-3 has active ingredients of cod liver oil. It is often used in high blood cholesterol. eHealthMe is studying from 2,130 Omega-3 users for its effectiveness, alternative drugs and more.

What is Pulmonary toxicity?

Pulmonary toxicity (side effects on the lungs) is found to be associated with 760 drugs and 411 conditions by eHealthMe.

Number of Omega-3 and Pulmonary toxicity reports submitted per year:

Gender of people who have Pulmonary toxicity when taking Omega-3 *:

female: 0.0 %
male: 100 %

Age of people who have Pulmonary toxicity when taking Omega-3 *:

Common drugs people take besides Omega-3 *:

Common side effects people have besides Pulmonary toxicity *:

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 100.00%
Pneumonia: 3 people, 100.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 100.00%
Hypotension (abnormally low blood pressure): 2 people, 66.67%
Drug Hypersensitivity: 2 people, 66.67%
High Blood Pressure: 2 people, 66.67%
Heart Transplant Rejection: 1 person, 33.33%
Acne (skin problems that cause pimples): 1 person, 33.33%
Acute Respiratory Failure: 1 person, 33.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 33.33%

Common conditions people have *:

Tenderness (pain or discomfort when an affected area is touched): 2 people, 66.67%
Nausea (feeling of having an urge to vomit): 2 people, 66.67%
Gout (uric acid crystals building up in the body): 2 people, 66.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 66.67%
Abdominal Pain Upper: 2 people, 66.67%
Transplant Rejection (a transplant material is not worked): 1 person, 33.33%
Immunodeficiency Disorders: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 and have Pulmonary toxicity?

Check whether Pulmonary toxicity is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pulmonary toxicity and when was it recovered:

Pulmonary toxicity in Omega-3

Expand to all the drugs that have ingredients of cod liver oil:

Pulmonary toxicity and drugs with ingredients of cod liver oil

Alternative drugs to, pros and cons of Omega-3:

Omega-3 (2,130 reports)

Common Omega-3 side effects:

Fatigue (feeling of tiredness): 246 reports
Diarrhea: 168 reports
Drug ineffective: 152 reports
Pain: 151 reports
Rashes (redness): 132 reports
Joint pain: 128 reports
High blood pressure: 117 reports
Weakness: 116 reports

Browse all side effects of Omega-3:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pulmonary toxicity treatments and more:

Pulmonary toxicity (5,396 reports)

COVID vaccines that are related to Pulmonary toxicity:

Common drugs associated with Pulmonary toxicity:

How the study uses the data?

The study uses data from the FDA. It is based on cod liver oil (the active ingredients of Omega-3) and Omega-3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.